{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:44:57Z","timestamp":1786373097302,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.2215\/cjn.07610520","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T15:27:01Z","timestamp":1591889221000},"page":"923-925","source":"Crossref","is-referenced-by-count":2,"title":["ADPKD, Tolvaptan, and Nephrolithiasis Risk"],"prefix":"10.2215","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8738-3571","authenticated-orcid":false,"given":"Ewout J.","family":"Hoorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zietse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0272-6386(88)80137-9","article-title":"The association of nephrolithiasis and autosomal dominant polycystic kidney disease","volume":"11","author":"Torres","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2215\/CJN.03100608","article-title":"Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients","volume":"4","author":"Nishiura","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.juro.2015.11.027","article-title":"Short-term tolvaptan increases water intake and effectively decreases urinary calcium oxalate, calcium phosphate and uric acid supersaturations","volume":"195","author":"Cheungpasitporn","year":"2016","journal-title":"J Urol"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"e0203942","DOI":"10.1371\/journal.pone.0203942","article-title":"Hyponatremia and the risk of kidney stones: A matched case-control study in a large U.S. Health system","volume":"13","author":"Tominaga","year":"2018","journal-title":"PLoS One"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2215\/CJN.13861119","article-title":"Urinary lithogenic risk profile in ADPKD patients treated with tolvaptan","volume":"15","author":"Bargagli","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.ajkd.2016.08.028","article-title":"Tolvaptan and kidney pain in patients with autosomal dominant polycystic kidney disease: Secondary analysis from a randomized controlled trial","volume":"69","author":"Casteleijn","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40620-015-0210-4","article-title":"Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: A systematic review and meta-analysis","volume":"29","author":"Cheungpasitporn","year":"2016","journal-title":"J Nephrol"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"130","author":"Torres","year":"2019","journal-title":"J Clin Invest"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1681\/ASN.2018080816","article-title":"Vasopressin increases urinary acidification via V1a receptors in collecting duct intercalated cells","volume":"30","author":"Giesecke","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1113\/JP272053","article-title":"Role of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion","volume":"594","author":"Pais","year":"2016","journal-title":"J Physiol"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1073\/pnas.1318257110","article-title":"Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia","volume":"110","author":"Tamma","year":"2013","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.07610520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:42:18Z","timestamp":1786369338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.07610520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.07610520","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]}}}